Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients

计划入组 48 人 · 首次发布于 2010 年 6 月 24 日

A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma

计划入组 1,200 人 · 首次发布于 2022 年 1 月 14 日

Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine

计划入组 39 人 · 首次发布于 2007 年 11 月 19 日

Bacillus calmette-guerin substrain russian BCG-I live antigen(VERITY-BCG)

hepatocellular carcinoma program

Hepatocellular carcinoma(Engitix)

Senti Biosciences, Inc.

United States

Capillary Biomedical, Inc.

United States

Cabozantinib Fails to Show Overall Survival Benefit in Papillary Renal Cell Carcinoma

Vivos Receives FDA IDE Approval for First-in-Human RadioGel Trial in Non-Resectable Papillary Thyroid Carcinoma

Bevacizumab-Erlotinib Combination Shows Remarkable 72% Response Rate in Rare HLRCC-Associated Kidney Cancer